0 0 bet365
0 0 bet365
U5sètpĺÙΩÎZ} ÆCA@u_™OU›}”±†∫NÂá˙Ô
÷∂°˚≥˛Ë…»»»»ìë¿˙ˇ¨çD"ëìÚ{âŒ˙xöL±@‘€q˙Û˜ˇ]?z˛·ıÕü?z}≤>˙√≥˜fiΩÜlRñüŒØÀÚ˘Õs¯”onfi¶E7]‰ƒ‚–îÂã2»˙î|]ñ€Ì∂ÿŒ ]yÛqπÎì5”Ú˘ÕÛÚßIìV˜U°ìŒ6ßk•§v÷∏xÂ.”ÂrY"êóWÑzs
ù=Ω∂î˙î¸ÑÓØ2%.ëKìÙ‡)É´Ø≤DªTͬ˛
Tè!R∫R;πÃJ¿'€◊®zö\ãKA‚ùÿbT+¡f Û :r"ÙûÜs«°•´ld⁄z I˜–fi≤N˝ï¶ëMËLÏ81öIThËjZTπ≈€¡éÜHaå46ÜÆúËΩ?ó8⁄`7 ¥“ ¥ÅG∏ïN‚dj4ÆÀÖf+Å|ı;zÿJ–±
o …Éhå`ÿÅÈbÿ˝ïìÉ.˝ú¢
0 0 bet3650 0 bet3650 0 bet365
Soberana 02 or Soberana 2, technical name FINLAY-FR-2, is a COVID-19 vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. The vaccine is known as PastoCovac (Persian: ~'3*HHH) in Iran, where it has been developed in collaboration with the Pasteur Institute of Iran.
Two doses of SOBERANA-02 was 69.7% (95%CI 56.5 78.9) and 74.9% (95%CI 33.7 90.5) efficacious against symptomatic and severe COVID-19, respectively.
0 0 bet3650 0 bet365
0 0 bet3650 0 bet365